1. 35MO Number of IL-2 doses and clinical outcomes of tumor-infiltrating lymphocyte (TIL) cell therapy: Post hoc analysis of the C-144-01 trial of lifileucel in patients with advanced melanoma. (December 2022) Authors: Hassel, J.C.; Sarnaik, A.; Chesney, J.; Medina, T.; Hamid, O.; Thomas, S.; Wermke, M.; Domingo-Musibay, E.; Kirkwood, J.M.; Larkin, J.; Weber, J.S.; Arance Fernandez, A.M.; Rodriguez, J.F.; Thomas, I.; Corrie, P.G.; Gontcharova, V.; Wu, X.; Shi, W.; Kluger, H. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A prospective observational safety study of patients with BRAFV600‐mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study). (10th February 2019) Authors: Corrie, P.G.; Terheyden, P.; ten Tije, A.J.; Herbst, R.; Jansen, R.; Marples, M.; Debus, D.; Marconcini, R.; Blasinska‐Morawiec, M.; Freivogel, K.; Munson, M.L.G.; Goodman, G.R.; Hsu, J.J.; Sadetsky, N.; Colburn, D.; Rutkowski, P. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A prospective observational safety study of patients with BRAFV600‐mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study). (1st May 2019) Authors: Corrie, P.G.; Terheyden, P.; ten Tije, A.J.; Herbst, R.; Jansen, R.; Marples, M.; Debus, D.; Marconcini, R.; Blasinska‐Morawiec, M.; Freivogel, K.; Munson, M.L.G.; Goodman, G.R.; Hsu, J.J.; Sadetsky, N.; Colburn, D.; Rutkowski, P. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safeguarding Clinical Research in the National Health Service. Issue 5 (May 2023) Authors: Corrie, P.G.; Wadsley, J. Journal: Clinical oncology Issue: Volume 35:Issue 5(2023) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic. Issue 10 (October 2021) Authors: Favara, D.M.; McAdam, K.; Cooke, A.; Bordessa-Kelly, A.; Budriunaite, I.; Bossingham, S.; Houghton, S.; Doffinger, R.; Ainsworth, N.; Corrie, P.G. Journal: Clinical oncology Issue: Volume 33:Issue 10(2021) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗